Particle engineering of excipients for direct compression: understanding the role of material properties

Sharad Mangal, Felix Meiser, David Morton, Ian Larson

Research output: Contribution to journalArticleResearchpeer-review

20 Citations (Scopus)

Abstract

Tablets represent the preferred and most commonly dispensed pharmaceutical dosage form for administering active pharmaceutical ingredients (APIs). Minimizing the cost of goods and improving manufacturing output efficiency has motivated companies to use direct compression as a preferred method of tablet manufacturing. Excipients dictate the success of direct compression, notably by optimizing powder formulation compactability and flow, thus there has been a surge in creating excipients specifically designed to meet these needs for direct compression. Greater scientific understanding of tablet manufacturing coupled with effective application of the principles of material science and particle engineering has resulted in a number of improved direct compression excipients. Despite this, significant practical disadvantages of direct compression remain relative to granulation, and this is partly due to the limitations of direct compression excipients. For instance, in formulating high-dose APIs, a much higher level of excipient is required relative to wet or dry granulation and so tablets are much bigger. Creating excipients to enable direct compression of high-dose APIs requires the knowledge of the relationship between fundamental material properties and excipient functionalities. In this paper, we review the current understanding of the relationship between fundamental material properties and excipient functionality for direct compression.
Original languageEnglish
Pages (from-to)5877-5889
Number of pages13
JournalCurrent Pharmaceutical Design
Volume21
Issue number40
DOIs
Publication statusPublished - 2015

Keywords

  • Compactability
  • Direct compression
  • Excipients
  • Flow
  • Inter-particle interaction
  • Tableting

Cite this

@article{65cc8f611c1e4b719af0490020d1b3a4,
title = "Particle engineering of excipients for direct compression: understanding the role of material properties",
abstract = "Tablets represent the preferred and most commonly dispensed pharmaceutical dosage form for administering active pharmaceutical ingredients (APIs). Minimizing the cost of goods and improving manufacturing output efficiency has motivated companies to use direct compression as a preferred method of tablet manufacturing. Excipients dictate the success of direct compression, notably by optimizing powder formulation compactability and flow, thus there has been a surge in creating excipients specifically designed to meet these needs for direct compression. Greater scientific understanding of tablet manufacturing coupled with effective application of the principles of material science and particle engineering has resulted in a number of improved direct compression excipients. Despite this, significant practical disadvantages of direct compression remain relative to granulation, and this is partly due to the limitations of direct compression excipients. For instance, in formulating high-dose APIs, a much higher level of excipient is required relative to wet or dry granulation and so tablets are much bigger. Creating excipients to enable direct compression of high-dose APIs requires the knowledge of the relationship between fundamental material properties and excipient functionalities. In this paper, we review the current understanding of the relationship between fundamental material properties and excipient functionality for direct compression.",
keywords = "Compactability, Direct compression, Excipients, Flow, Inter-particle interaction, Tableting",
author = "Sharad Mangal and Felix Meiser and David Morton and Ian Larson",
year = "2015",
doi = "10.2174/1381612821666151008125117",
language = "English",
volume = "21",
pages = "5877--5889",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers",
number = "40",

}

Particle engineering of excipients for direct compression: understanding the role of material properties. / Mangal, Sharad; Meiser, Felix; Morton, David; Larson, Ian.

In: Current Pharmaceutical Design, Vol. 21, No. 40, 2015, p. 5877-5889.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Particle engineering of excipients for direct compression: understanding the role of material properties

AU - Mangal, Sharad

AU - Meiser, Felix

AU - Morton, David

AU - Larson, Ian

PY - 2015

Y1 - 2015

N2 - Tablets represent the preferred and most commonly dispensed pharmaceutical dosage form for administering active pharmaceutical ingredients (APIs). Minimizing the cost of goods and improving manufacturing output efficiency has motivated companies to use direct compression as a preferred method of tablet manufacturing. Excipients dictate the success of direct compression, notably by optimizing powder formulation compactability and flow, thus there has been a surge in creating excipients specifically designed to meet these needs for direct compression. Greater scientific understanding of tablet manufacturing coupled with effective application of the principles of material science and particle engineering has resulted in a number of improved direct compression excipients. Despite this, significant practical disadvantages of direct compression remain relative to granulation, and this is partly due to the limitations of direct compression excipients. For instance, in formulating high-dose APIs, a much higher level of excipient is required relative to wet or dry granulation and so tablets are much bigger. Creating excipients to enable direct compression of high-dose APIs requires the knowledge of the relationship between fundamental material properties and excipient functionalities. In this paper, we review the current understanding of the relationship between fundamental material properties and excipient functionality for direct compression.

AB - Tablets represent the preferred and most commonly dispensed pharmaceutical dosage form for administering active pharmaceutical ingredients (APIs). Minimizing the cost of goods and improving manufacturing output efficiency has motivated companies to use direct compression as a preferred method of tablet manufacturing. Excipients dictate the success of direct compression, notably by optimizing powder formulation compactability and flow, thus there has been a surge in creating excipients specifically designed to meet these needs for direct compression. Greater scientific understanding of tablet manufacturing coupled with effective application of the principles of material science and particle engineering has resulted in a number of improved direct compression excipients. Despite this, significant practical disadvantages of direct compression remain relative to granulation, and this is partly due to the limitations of direct compression excipients. For instance, in formulating high-dose APIs, a much higher level of excipient is required relative to wet or dry granulation and so tablets are much bigger. Creating excipients to enable direct compression of high-dose APIs requires the knowledge of the relationship between fundamental material properties and excipient functionalities. In this paper, we review the current understanding of the relationship between fundamental material properties and excipient functionality for direct compression.

KW - Compactability

KW - Direct compression

KW - Excipients

KW - Flow

KW - Inter-particle interaction

KW - Tableting

UR - http://www.eurekaselect.com/135610/article

U2 - 10.2174/1381612821666151008125117

DO - 10.2174/1381612821666151008125117

M3 - Article

VL - 21

SP - 5877

EP - 5889

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 40

ER -